Chinese Academy of Sciences

Crown Bioscience, Inc. (taicang)

Crown Bioscience Inc.

Mengmeng Yang

Jing Min Xu

Jiang Yan

Hongli Wang

Chunlong Li

Henry Qixiang Li

Bo Tang

Bangming Chen

Zhaoyun Tang

Yefeng Xu

The present invention provides methods for the treatment of lung cancer patients, especially NSCLC with SCC or PLC using a drug against EGFR, such as an anti-EGFR antibody treatment, e.g., cetuximab. In addition, the present invention provides methods for identification or selection of lung cancer patients for the treatment with a drug against EGFR, such as an anti-EGFR antibody treatment, e.g., cetuximab based on histological determinations.

Histological markers for identifying non-small cell lung carcinoma patients for treatment with an anti-EGFR drug

A semiconductor device, including: a substrate having a first semiconductor material; a second semiconductor layer on the substrate; a third semiconductor layer on the second semiconductor layer and being a device formation region; an isolation structure on both sides of the third semiconductor layer and on the substrate; and an insulating layer below the source and drain regions of the third semiconductor layer and between the isolation structure and the ends of the second semiconductor layer.

Semiconductor device and method for manufacturing the same

Growing community of inventors

Beijing, China

Mengmeng Yang